Bank Of America Corp Biomea Fusion, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 116,415 shares of BMEA stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

116,415

Previous 305,953 61.95%

Holding current value

$1.03 Million

Previous $4.57 Million 88.56%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.14 - $15.3 $784,687 - $2.9 Million	-189,538 Reduced 61.95%	116,415 $523,000
Q1 2024 May 15, 2024	BUY	$13.92 - $19.5 $2.73 Million - $3.83 Million	196,262 Added 178.92%	305,953 $4.57 Million
Q4 2023 Feb 14, 2024	SELL	$8.37 - $19.8 $598,321 - $1.42 Million	-71,484 Reduced 39.46%	109,691 $1.59 Million
Q2 2023 Aug 14, 2023	BUY	$21.66 - $41.8 $2.32 Million - $4.48 Million	107,112 Added 144.62%	181,175 $3.98 Million
Q1 2023 May 12, 2023	BUY	$6.8 - $32.35 $219,422 - $1.04 Million	32,268 Added 77.21%	74,063 $2.3 Million
Q4 2022 Feb 10, 2023	SELL	$6.3 - $11.6 $52,888 - $97,382	-8,395 Reduced 16.73%	41,795 $352,000
Q3 2022 Nov 14, 2022	BUY	$9.51 - $13.61 $212,348 - $303,897	22,329 Added 80.14%	50,190 $490,000
Q2 2022 Aug 12, 2022	SELL	$3.0 - $12.03 $484,650 - $1.94 Million	-161,550 Reduced 85.29%	27,861 $333,000
Q1 2022 May 16, 2022	BUY	$4.39 - $9.03 $272,425 - $560,365	62,056 Added 48.73%	189,411 $845,000
Q4 2021 Feb 08, 2022	BUY	$7.22 - $12.72 $539,680 - $950,794	74,748 Added 142.09%	127,355 $949,000
Q3 2021 Nov 15, 2021	BUY	$10.0 - $15.99 $476,100 - $761,283	47,610 Added 952.77%	52,607 $630,000
Q2 2021 Sep 13, 2021	BUY	$13.65 - $20.93 $68,209 - $104,587	4,997 New	4,997 $78,000

Others Institutions Holding BMEA

# of Institutions

120

Shares Held

17.9M

Call Options Held

978K

Put Options Held

286K

View Full List

About Biomea Fusion, Inc.

Ticker BMEA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,290,600
Market Cap $260M
Description
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...

More about BMEA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Biomea Fusion, Inc. Transaction History